The authors reply:

Kidney International

Volumn 79, Issue 8, 2011, Pages 921-

  Sage, Andrew P ^a   Tintut, Yin ^b   Demer, Linda L ^b,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CALCIUM; HYDROXYAPATITE; NANOCRYSTAL; OSTEOPONTIN; PHOSPHATE;

BLOOD VESSEL CALCIFICATION; BONE MINERALIZATION; GENE INDUCTION; HYPERPHOSPHATEMIA; IN VITRO STUDY; LETTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 79953242004     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.562     Document Type: Letter

References (4)

1. Villa-Bellosta R, Sorribas V. On the osteogenic expression induced by calcium/phosphate deposition. Kidney Int 2011; 79: 921.
2. Villa-Bellosta R, Millan A, Sorribas V. Role of calcium-phosphate deposition in vascular smooth muscle cell calcification. Am J Physiol Cell Physiol 2011; 300: C210-C220.
3. Sage AP, Lu J, Tintut Y et al. Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int 2011; 79: 414-422.
4. George A, Veis A. Phosphorylated proteins and control over apatite nucleation, crystal growth, and inhibition. Chem Rev 2008; 108: 4670-4693.